180 related articles for article (PubMed ID: 31208087)
1. Interventions to Increase the Rate of Influenza and Pneumococcal Vaccination in Patients with Chronic Obstructive Pulmonary Disease: A Scoping Review.
Trethewey SP; Patel N; Turner AM
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31208087
[No Abstract] [Full Text] [Related]
2. Prophylactic vaccinations in chronic obstructive pulmonary disease: current status.
Varkey JB; Varkey AB; Varkey B
Curr Opin Pulm Med; 2009 Mar; 15(2):90-9. PubMed ID: 19532022
[TBL] [Abstract][Full Text] [Related]
3. Influenza and Pneumonia Vaccination Rates and Factors Affecting Vaccination among Patients with Chronic Obstructive Pulmonary Disease.
Aka Aktürk Ü; Görek Dilektaşlı A; Şengül A; Musaffa Salepçi B; Oktay N; Düger M; Arık Taşyıkan H; Durmuş Koçak N
Balkan Med J; 2017 May; 34(3):206-211. PubMed ID: 28443565
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing acceptance of influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease.
Saiphoklang N; Phadungwatthanachai J
Hum Vaccin Immunother; 2022 Nov; 18(6):2102840. PubMed ID: 35943223
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Pharmacist-Initiated Interventions on Vaccination Rates in Patients with Asthma or COPD.
Klassing HM; Ruisinger JF; Prohaska ES; Melton BL
J Community Health; 2018 Apr; 43(2):297-303. PubMed ID: 28852915
[TBL] [Abstract][Full Text] [Related]
6. [Effect of influenza and 23-valent pneumococcal polysaccharide vaccinations on elderly with chronic obstructive pulmonary diseases: a community-based intervention study].
Wen Y; He L; Zhai Y; Wu J; Chen YY; Wang H; Zong QQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):792-798. PubMed ID: 29936749
[No Abstract] [Full Text] [Related]
7. Does pulmonary subspecialty referral from primary care affect the adherence to vaccination recommendations in COPD patients?
Ehteshami-Afshar S; Crothers K; Rodwin B; Bade B; Brandt C; Akgün KM
Respir Res; 2021 Feb; 22(1):50. PubMed ID: 33579277
[TBL] [Abstract][Full Text] [Related]
8. Are younger COPD patients adequately vaccinated for influenza and pneumococcus?
Gogou E; Hatzoglou C; Zarogiannis SG; Siachpazidou D; Gerogianni I; Kotsiou OS; Varsamas C; Gourgoulianis KI
Respir Med; 2022 Nov; 203():106988. PubMed ID: 36162248
[TBL] [Abstract][Full Text] [Related]
9. Influenza and pneumococcal vaccination coverage and associated factors in patients hospitalized with acute exacerbations of COPD in China: Findings from real-world data.
He R; Ren X; Huang K; Lei J; Niu H; Li W; Dong F; Li B; Wang Y; Yang T; Wang C
Chin Med J (Engl); 2024 May; 137(10):1179-1189. PubMed ID: 37488669
[TBL] [Abstract][Full Text] [Related]
10. [Progress in research of influenza vaccine and 23 valent pneumococcal polysaccharide vaccine immunization in patients with chronic obstructive pulmonary disease].
Sui HT; Guo Y; Yang ZN; Su JF; Shu X; Zhang Y; Wang HQ; Yang X
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Sep; 43(9):1508-1512. PubMed ID: 36117362
[TBL] [Abstract][Full Text] [Related]
11. Use of Pneumococcal and influenza vaccine in patients with COPD, asthma bronchiale and interstitial lung diseases in south east Germany.
Mohr A; Plentz A; Sieroslawski A; Pezenburg F; Pfeifer M; Salzberger B; Hitzenbichler F
Respir Med; 2020; 174():106207. PubMed ID: 33152552
[TBL] [Abstract][Full Text] [Related]
12. Compliance with influenza and pneumococcal vaccinations in Israel, 1999-2002.
Kaufman Z; Green MS
Public Health Rev; 2003; 31(1):71-9. PubMed ID: 14656044
[TBL] [Abstract][Full Text] [Related]
13. Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists.
Arabyat RM; Raisch DW; Bakhireva L
Res Social Adm Pharm; 2018 Feb; 14(2):162-169. PubMed ID: 28533080
[TBL] [Abstract][Full Text] [Related]
14. Association of standing-order policies with vaccination rates in dialysis clinics: a US-based cross-sectional study.
Bond TC; Patel PR; Krisher J; Sauls L; Deane J; Strott K; Karp S; McClellan W
Am J Kidney Dis; 2009 Jul; 54(1):86-94. PubMed ID: 19346041
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Inpatient Influenza and Pneumococcal Vaccination Acceptance Rates With Pharmacist Education.
Queeno BV
J Pharm Pract; 2017 Apr; 30(2):202-208. PubMed ID: 26880320
[TBL] [Abstract][Full Text] [Related]
16. [Which vaccines for COPD patients?].
Burgel PR
Rev Prat; 2024 Jan; 74(1):13-15. PubMed ID: 38329244
[TBL] [Abstract][Full Text] [Related]
17. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus.
Lawson EF; Trupin L; Yelin EH; Yazdany J
Semin Arthritis Rheum; 2015 Jun; 44(6):666-71. PubMed ID: 25701500
[TBL] [Abstract][Full Text] [Related]
18. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.
Granger R; Walters J; Poole PJ; Lasserson TJ; Mangtani P; Cates CJ; Wood-Baker R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001390. PubMed ID: 17054135
[TBL] [Abstract][Full Text] [Related]
19. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain.
Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P
J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991
[TBL] [Abstract][Full Text] [Related]
20. [Pneumococcal vaccine and influenza vaccine for prevention of exacerbation in patients with COPD].
Matsuse H
Nihon Rinsho; 2016 May; 74(5):839-42. PubMed ID: 27254956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
